Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-06-25T03:51:54.577Z Has data issue: false hasContentIssue false

Depression and mild cognitive impairment – Comorbidity and/or continuum?

Published online by Cambridge University Press:  23 March 2020

G. Sobreira*
Affiliation:
Centro Hospitalar Psiquiátrico de Lisboa, First Psychotic Episode Unit, Lisboa, Portugal
M.A. Aleixo
Affiliation:
Centro Hospitalar Psiquiátrico de Lisboa, First Psychotic Episode Unit, Lisboa, Portugal
C. Moreia
Affiliation:
Centro Hospitalar Psiquiátrico de Lisboa, Schizophrenia and Schizoaffective Disorders Unit, Lisboa, Portugal
J. Oliveira
Affiliation:
Centro Hospitalar Psiquiátrico de Lisboa, Neuropsychiatry and Dementia Unit, Lisboa, Portugal
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Depression and mild cognitive impairment are common among the elderly. Half the patients with late-life depression also present some degree of cognitive decline, making the distinction between these conditions difficult.

Objectives

To conduct a database review in order to understand the relationship between these entities, and treatment approaches.

Aims

To create and implement clinical guidelines at our institution, to evaluate and treat elderly patients presenting with depression and mild cognitive impairment.

Methods

A PubMed database search using as keywords “late life depression”, “depression”; “cognitive impairment”; “mild cognitive impairment” and “dementia” between the year 2008 and 2015.

Results

Late-life depression and cognitive impairment are frequent among the elderly (10–20%). Depression is also common in the early stages of dementia decreasing as the cognitive decline progresses. The causal relationship between these entities is not well understood and some authors advocate a multifactorial model (genetic risk factors; neuroendocrine changes; vascular risk factors) and the cognitive impairment of said changes is dependent on the individual's cognitive reserve. Regarding treatment of depression in patients with cognitive impairment, most authors advocate a stepped approach with watchful waiting and then, if symptoms persist, the introduction of pharmacotherapy and psychosocial intervention.

Conclusions

The relationship between cognitive impairment and depression is still not clear and probably multifactorial. The diagnosis of depressive symptoms in patients with severe cognitive impairment can be difficult and most forms of pharmacological treatment in this population are not beneficial, making it important to carefully evaluate the benefits of introducing new medication.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EW312
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.